Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury

gan Regan, Christopher P., Adam, Paul J., Madsen, Cort S., Owens, Gary K.
Cyhoeddwyd 2000

Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects

gan Regan, Christopher P., Li, Wei, Boucher, Diane M., Spatz, Stephen, Su, Michael S., Kuida, Keisuke
Cyhoeddwyd 2002

Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells

gan Taylor, Joan M., Mack, Christopher P., Nolan, Kate, Regan, Christopher P., Owens, Gary K., Parsons, J. Thomas
Cyhoeddwyd 2001

Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry

gan Lagrutta, Armando, Regan, Christopher P., Zeng, Haoyu, Imredy, John P., Koeplinger, Kenneth, Morissette, Pierre, Liu, Liping, Wollenberg, Gordon, Brynczka, Christopher, Lebrón, José, DeGeorge, Joseph, Sannajust, Frederick
Cyhoeddwyd yn Sci Rep (2017)

Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist

gan Bell, Ian M., Gallicchio, Steven N., Wood, Michael R., Quigley, Amy G., Stump, Craig A., Zartman, C. Blair, Fay, John F., Li, Chi-Chung, Lynch, Joseph J., Moore, Eric L., Mosser, Scott D., Prueksaritanont, Thomayant, Regan, Christopher P., Roller, Shane, Salvatore, Christopher A., Kane, Stefanie A., Vacca, Joseph P., Selnick, Harold G.
Cyhoeddwyd 2010